Technical Analysis for SNGX - Soligenix, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Down 3 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | -1.49% | |
| Stochastic Reached Oversold | Weakness | -1.49% | |
| BB Squeeze Ended | Range Expansion | -1.49% | |
| Oversold Stochastic | Weakness | -1.49% | |
| Lizard Bullish | Bullish Day Trade Setup | -5.70% | |
| Bollinger Band Squeeze | Range Contraction | -5.70% | |
| NR7 | Range Contraction | -5.70% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 12 hours ago |
| Fell Below Lower Bollinger Band | about 12 hours ago |
| Down 2 % | about 12 hours ago |
| Down 1% | about 15 hours ago |
| Lower Bollinger Band Support | about 15 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ' (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Treatment Radiation Gastrointestinal Therapeutic Products Toxins Biodefense Proteins Gastrointestinal Disease Biological Warfare Lectins Biotherapeutic Products
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Treatment Radiation Gastrointestinal Therapeutic Products Toxins Biodefense Proteins Gastrointestinal Disease Biological Warfare Lectins Biotherapeutic Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 32.0 |
| 52 Week Low | 1.8301 |
| Average Volume | 128,464 |
| 200-Day Moving Average | 5.78 |
| 50-Day Moving Average | 3.75 |
| 20-Day Moving Average | 3.60 |
| 10-Day Moving Average | 3.53 |
| Average True Range | 0.22 |
| RSI (14) | 38.65 |
| ADX | 18.44 |
| +DI | 15.37 |
| -DI | 17.30 |
| Chandelier Exit (Long, 3 ATRs) | 3.34 |
| Chandelier Exit (Short, 3 ATRs) | 3.93 |
| Upper Bollinger Bands | 3.91 |
| Lower Bollinger Band | 3.30 |
| Percent B (%b) | 0.02 |
| BandWidth | 17.07 |
| MACD Line | -0.09 |
| MACD Signal Line | -0.07 |
| MACD Histogram | -0.0218 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.50 | ||||
| Resistance 3 (R3) | 3.51 | 3.46 | 3.47 | ||
| Resistance 2 (R2) | 3.46 | 3.41 | 3.45 | 3.46 | |
| Resistance 1 (R1) | 3.38 | 3.38 | 3.36 | 3.37 | 3.45 |
| Pivot Point | 3.33 | 3.33 | 3.32 | 3.33 | 3.33 |
| Support 1 (S1) | 3.26 | 3.28 | 3.23 | 3.25 | 3.17 |
| Support 2 (S2) | 3.21 | 3.25 | 3.20 | 3.16 | |
| Support 3 (S3) | 3.13 | 3.21 | 3.15 | ||
| Support 4 (S4) | 3.12 |
